Genesys International 44th AGM: All 6 resolutions approved, including ESOP 2026
GENESYS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.2 pts more than Nifty Microcap 250 and 2.8 pts more than its IT Enabled Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
44th AGM held on Sept 30, 2026 via video conferencing. All 6 resolutions passed with requisite majority. Approvals include FY26 accounts (99.95 percent in favor), director reappointment of Dr Yogita Shukla, statutory auditors appointment, new ESOP Scheme 2026, ESOP for subsidiary employees, and variation in QIP issue objects from the May 2025 placement. About 44.8 percent voting turnout. Scrutinizer was CS Sanam Umbargikar of DSM and Associates.
Routine approvals passed with strong majority. New ESOP Scheme 2026 may dilute shares later. QIP variation changes use of May 2025 placement funds.